Tianjin Ringpu Bio-Technology Co.,Ltd. 300119.SZ Stock
Tianjin Ringpu Bio-Technology Co.,Ltd. Price Chart
Tianjin Ringpu Bio-Technology Co.,Ltd. 300119.SZ Financial and Trading Overview
Contents
Tianjin Ringpu Bio-Technology Co.,Ltd. stock price | 15.86 CNY |
Previous Close | 17.18 CNY |
Open | 17.28 CNY |
Bid | 17.44 CNY x 0 |
Ask | 17.45 CNY x 0 |
Day's Range | 17.13 - 17.59 CNY |
52 Week Range | 16.18 - 22.95 CNY |
Volume | 2.75M CNY |
Avg. Volume | 3.59M CNY |
Market Cap | 8.16B CNY |
Beta (5Y Monthly) | 0.94726 |
PE Ratio (TTM) | 22.649351 |
EPS (TTM) | 0.98 CNY |
Forward Dividend & Yield | 0.3 (1.76%) |
Ex-Dividend Date | June 8, 2023 |
1y Target Est | 25.5 CNY |
300119.SZ Valuation Measures
Enterprise Value | 7.28B CNY |
Trailing P/E | 22.649351 |
Forward P/E | 13.312978 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 3.8208778 |
Price/Book (mrq) | 1.8799181 |
Enterprise Value/Revenue | 3.408 |
Enterprise Value/EBITDA | 15.628 |
Trading Information
Tianjin Ringpu Bio-Technology Co.,Ltd. Stock Price History
Beta (5Y Monthly) | 0.94726 |
52-Week Change | 0.46% |
S&P500 52-Week Change | 20.43% |
52 Week High | 22.95 CNY |
52 Week Low | 16.18 CNY |
50-Day Moving Average | 20.09 CNY |
200-Day Moving Average | 20.26 CNY |
300119.SZ Share Statistics
Avg. Volume (3 month) | 3.59M CNY |
Avg. Daily Volume (10-Days) | 3.09M CNY |
Shares Outstanding | 468.02M |
Float | 241.26M |
Short Ratio | N/A |
% Held by Insiders | 48.09% |
% Held by Institutions | 10.26% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.3 |
Trailing Annual Dividend Yield | 1.74% |
5 Year Average Dividend Yield | 150.00% |
Payout Ratio | 0.4566 |
Last Split Factor | 19.93579:10 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 16.63% |
Operating Margin (ttm) | 16.58% |
Gross Margin | 48.78% |
EBITDA Margin | 21.80% |
Management Effectiveness
Return on Assets (ttm) | 3.80% |
Return on Equity (ttm) | 8.53% |
Income Statement
Revenue (ttm) | 2.14B CNY |
Revenue Per Share (ttm) | 4.61 CNY |
Quarterly Revenue Growth (yoy) | 13.30% |
Gross Profit (ttm) | N/A |
EBITDA | 465.79M CNY |
Net Income Avi to Common (ttm) | 355.32M CNY |
Diluted EPS (ttm) | 0.77 |
Quarterly Earnings Growth (yoy) | 11.89% |
Balance Sheet
Total Cash (mrq) | 1.67B CNY |
Total Cash Per Share (mrq) | 3.6 CNY |
Total Debt (mrq) | 698.54M CNY |
Total Debt/Equity (mrq) | 15.23 CNY |
Current Ratio (mrq) | 2.599 |
Book Value Per Share (mrq) | 9.277 |
Cash Flow Statement
Operating Cash Flow (ttm) | 473.24M CNY |
Levered Free Cash Flow (ttm) | 231.17M CNY |
Profile of Tianjin Ringpu Bio-Technology Co.,Ltd.
Country | China |
State | N/A |
City | Tianjin |
Address | No. 1, Dongjiu Road |
ZIP | 300308 |
Phone | 86 22 8895 8000 |
Website | https://www.ringpu.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 2478 |
Tianjin Ringpu Bio-Technology Co.,Ltd. engages in the research and development, production, and sales of veterinary biological products, veterinary drug preparations, functional additives, and veterinary raw materials in China. The company provides vaccines and drugs for poultry, swine, and other animals; pet products comprising pet rabies inactivated vaccine, recombinant canine-a interferon, inhalation anesthetics isoflurane and sevoflurane for dogs and cats, cefquinoxime sulfate for injection for prevention and treatment of pet bacterial diseases, heart disease drugs for dogs and cats, napril chewable tablets and other products; and waterfowl products, including duck tempusu live/inactivated vaccine, gosling plague refined egg yolk antibody, duck infectious serositis inactivated vaccine, duck viral hepatitis refined egg yolk antibody, duck plague live vaccine, florfenicol soluble powder, kanamycin injection, etc. It also offers antifungal products, such as natural plant extracts, immune polysaccharides, clostridium butyricum, lactobacillus plantarum, antibacterial peptides, enzyme preparations, acidulants, etc; disinfection and cleaning products, consisting of potassium hydrogen persulfate composite powder, benzyl trimethyl ammonium chloride solution, deca methyl ammonium bromide solution, sodium dichloroisocyanurate, iodine glycerin solution, etc.; and APIs comprising tilmicosin, tilmicosin phosphate, monbutone, tidiroxine, florfenicol, vonimulin hydrochloride, gamimycin, etc. The company was founded in 1998 and is based in Tianjin, China.
Q&A For Tianjin Ringpu Bio-Technology Co.,Ltd. Stock
What is a current 300119.SZ stock price?
Tianjin Ringpu Bio-Technology Co.,Ltd. 300119.SZ stock price today per share is 15.86 CNY.
How to purchase Tianjin Ringpu Bio-Technology Co.,Ltd. stock?
You can buy 300119.SZ shares on the Shenzhen exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Tianjin Ringpu Bio-Technology Co.,Ltd.?
The stock symbol or ticker of Tianjin Ringpu Bio-Technology Co.,Ltd. is 300119.SZ.
Which industry does the Tianjin Ringpu Bio-Technology Co.,Ltd. company belong to?
The Tianjin Ringpu Bio-Technology Co.,Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Tianjin Ringpu Bio-Technology Co.,Ltd. have in circulation?
The max supply of Tianjin Ringpu Bio-Technology Co.,Ltd. shares is 466.28M.
What is Tianjin Ringpu Bio-Technology Co.,Ltd. Price to Earnings Ratio (PE Ratio)?
Tianjin Ringpu Bio-Technology Co.,Ltd. PE Ratio is 16.18367200 now.
What was Tianjin Ringpu Bio-Technology Co.,Ltd. earnings per share over the trailing 12 months (TTM)?
Tianjin Ringpu Bio-Technology Co.,Ltd. EPS is 0.98 CNY over the trailing 12 months.
Which sector does the Tianjin Ringpu Bio-Technology Co.,Ltd. company belong to?
The Tianjin Ringpu Bio-Technology Co.,Ltd. sector is Healthcare.